Chemicals & Advanced Materials Global On demand · 24-48h

Global Co-NTA Resin Market Strategic Research Report

Global Co-NTA Resin Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Co-NTA Resin Market
$41.092025
8.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Loose Agarose Resin, Magnetic Beads, Prepacked Spin Column, Prepacked Gravity Column, Prepacked FPLC Column, Purification Kit, Other

By Application: His-Tagged Protein Purification, Recombinant Protein Capture, High-Purity Protein Preparation, Structural Biology Sample Preparation, Enzyme And Antigen Preparation, Protein Pull-Down, Workflow Screening

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Cube Biotech, G-Biosciences, Abcam, Genaxxon Bioscience, UBPBio, Protein Ark, SignalChem Diagnostics, Smart-Lifesciences, Abbkine, Marvelgent Biosciences

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 118 pages
Market size 2025
$41.09
Million USD
Forecast CAGR
8.5%
2025-2032
Forecast 2032
$72.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Co-NTA Resin market size is predicted to grow from US$ 41.09 million in 2025 to US$ 73.44 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

Co-NTA resin is a metal chelate affinity chromatography medium in which NTA chelating groups are immobilized on agarose, magnetic agarose, or other porous supports and pre-loaded with Co²⁺ ions. It is primarily used for the capture, purification, and small-scale preparation of His-tagged recombinant proteins. The gross margin is approximately 60%.

Co-NTA resin represents a high-purity niche within His-tag protein purification consumables. Its overall market size is significantly smaller than that of Ni-NTA resin but maintains stable demand in research laboratories, early-stage biopharmaceutical development, structural biology, and protein–protein interaction studies. Its core value lies in the relatively higher selectivity of cobalt ions for histidine tags, which reduces host contaminants, weakly bound proteins, and background band interference. Therefore, it is often used for recombinant protein samples requiring higher purity and lower nonspecific binding.

From the demand side, Co-NTA resin is mainly driven by recombinant protein expression, antigen preparation, enzyme engineering, antibody fragment research, and proteomics validation experiments. Most users adopt Co-NTA as a “cleaner but slightly lower-capacity” alternative alongside Ni-NTA for difficult-to-purify proteins, downstream functional experiment samples, or detection systems sensitive to background. Magnetic Co-NTA products also benefit from small-volume, high-throughput, and automated sample processing needs, making them suitable for 96-well plates, small-scale screening, and parallel purification of multiple samples.

In terms of competition, these products are supplied by international life science reagent companies, chromatography medium manufacturers, and some domestic biotech reagent firms. Leading brands excel in matrix stability, batch-to-batch consistency, metal ion leakage control, and complementary buffer systems, while domestic suppliers compete mainly on price, delivery speed, and localized application support. Future growth is unlikely to come from large-scale industrial protein purification replacement but will come from continued repurchase in research and early development, as well as the adoption of magnetic beads, pre-packed columns, and high-throughput product formats. Overall, Co-NTA resin is a small but stable, high-unit-price, mid-technical-barrier specialty affinity purification consumable.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Co-NTA Resin market?

What factors are driving Co-NTA Resin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Co-NTA Resin market opportunities vary by end market size?

How does Co-NTA Resin break out by Type, by Application?

This report presents a comprehensive overview of the global Co-NTA Resin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Loose Agarose Resin
  • Magnetic Beads
  • Prepacked Spin Column
  • Prepacked Gravity Column
  • Prepacked FPLC Column
  • Purification Kit
  • Other

Segment by Matrix Type

  • Standard Agarose
  • Fast Flow Agarose
  • High-Crosslinked Agarose
  • Magnetic Agarose
  • Other

Segment by Operation Mode

  • Batch Binding
  • Gravity Column
  • Spin Column
  • FPLC Column
  • Magnetic Separation
  • Other

Segment by Application

  • His-Tagged Protein Purification
  • Recombinant Protein Capture
  • High-Purity Protein Preparation
  • Structural Biology Sample Preparation
  • Enzyme And Antigen Preparation
  • Protein Pull-Down
  • Workflow Screening

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Co-NTA Resin market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in His-Tagged Protein Purification, Recombinant Protein Capture, High-Purity Protein Preparation evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Co-NTA Resin Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$41.09
2025
Forecast
$72.7
2032
CAGR
8.5%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificCube BiotechG-BiosciencesAbcamGenaxxon BioscienceUBPBioProtein ArkSignalChem Diagnostics
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Loose Agarose ResinMagnetic BeadsPrepacked Spin ColumnPrepacked Gravity ColumnPrepacked FPLC ColumnPurification KitOther
By Application
His-Tagged Protein PurificationRecombinant Protein CaptureHigh-Purity Protein PreparationStructural Biology Sample PreparationEnzyme And Antigen PreparationProtein Pull-DownWorkflow Screening

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Loose Agarose Resin
  • 3.1.3 Magnetic Beads
  • 3.1.4 Prepacked Spin Column
  • 3.1.5 Prepacked Gravity Column
  • 3.1.6 Prepacked FPLC Column
  • 3.1.7 Purification Kit
  • 3.1.8 Other
  • 3.1.9 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 His-Tagged Protein Purification
  • 4.1.3 Recombinant Protein Capture
  • 4.1.4 High-Purity Protein Preparation
  • 4.1.5 Structural Biology Sample Preparation
  • 4.1.6 Enzyme And Antigen Preparation
  • 4.1.7 Protein Pull-Down
  • 4.1.8 Workflow Screening
  • 4.1.9 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cube Biotech
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 G-Biosciences
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Abcam
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Genaxxon Bioscience
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 UBPBio
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Protein Ark
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SignalChem Diagnostics
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Smart-Lifesciences
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Abbkine
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Marvelgent Biosciences
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Co-NTA Resin market?
The global Co-NTA Resin market is estimated at US$ 41.09 million in 2025 (base year) and is projected to reach US$ 73.44 million by 2032.
What is the forecast CAGR for the Co-NTA Resin market?
The market is expected to grow at a CAGR of 8.5% from 2026 to 2032, expanding from US$ 41.09 million in 2025 to US$ 73.44 million in 2032, roughly 1.8 times its base-year value.
What is Co-NTA Resin?
Co-NTA resin is a metal chelate affinity chromatography medium in which NTA chelating groups are immobilized on agarose, magnetic agarose, or other porous supports and pre-loaded with Co²⁺ ions. It is primarily used for the capture, purification, and small-scale preparation of His-tagged recombinant proteins. The gross margin is approximately 60%.
What are the main segments of the Co-NTA Resin market by type?
By type, the market is segmented into Loose Agarose Resin, Magnetic Beads, Prepacked Spin Column, Prepacked Gravity Column, Prepacked FPLC Column, Purification Kit and Other.
Which applications drive demand in the Co-NTA Resin market?
Key applications covered include His-Tagged Protein Purification, Recombinant Protein Capture, High-Purity Protein Preparation, Structural Biology Sample Preparation, Enzyme And Antigen Preparation, Protein Pull-Down and Workflow Screening.
Who are the key players in the Co-NTA Resin market?
Key players profiled include Thermo Fisher Scientific, Cube Biotech, G-Biosciences, Abcam, Genaxxon Bioscience, UBPBio, Protein Ark and SignalChem Diagnostics, among 11 companies covered in total.
Which regions and countries are covered for Co-NTA Resin?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Co-NTA Resin market?
From the demand side, Co-NTA resin is mainly driven by recombinant protein expression, antigen preparation, enzyme engineering, antibody fragment research, and proteomics validation experiments.
What challenges does the Co-NTA Resin market face?
Overall, Co-NTA resin is a small but stable, high-unit-price, mid-technical-barrier specialty affinity purification consumable.
Who should buy the Co-NTA Resin market report?
The report is intended for manufacturers and solution providers, distributors and end users in His-Tagged Protein Purification, Recombinant Protein Capture and High-Purity Protein Preparation, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Co-NTA Resin market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.